Poland · Delayed Price · Currency is PLN Massmedica Statistics
Total Valuation
Massmedica has a market cap or net worth of PLN 12.75 million. The enterprise value is 21.44 million.
| Market Cap | 12.75M |
| Enterprise Value | 21.44M |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Massmedica has 2.41 million shares outstanding.
| Current Share Class | 2.41M |
| Shares Outstanding | 2.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 64.05% |
| Owned by Institutions (%) | n/a |
| Float | 635,205 |
Valuation Ratios
The trailing PE ratio is 20.62.
| PE Ratio | 20.62 |
| Forward PE | n/a |
| PS Ratio | 0.40 |
| PB Ratio | 2.09 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 34.68 |
| EV / Sales | 0.67 |
| EV / EBITDA | 9.61 |
| EV / EBIT | 12.37 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.49.
| Current Ratio | 1.27 |
| Quick Ratio | 0.48 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | 4.08 |
| Debt / FCF | -4.00 |
| Interest Coverage | 2.99 |
Financial Efficiency
Return on equity (ROE) is 10.54% and return on invested capital (ROIC) is 7.32%.
| Return on Equity (ROE) | 10.54% |
| Return on Assets (ROA) | 4.35% |
| Return on Invested Capital (ROIC) | 7.32% |
| Return on Capital Employed (ROCE) | 21.37% |
| Weighted Average Cost of Capital (WACC) | 5.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 14 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 1.25 |
Taxes
In the past 12 months, Massmedica has paid 371,812 in taxes.
| Income Tax | 371,812 |
| Effective Tax Rate | 37.55% |
Stock Price Statistics
The stock price has increased by +60.35% in the last 52 weeks. The beta is 0.36, so Massmedica's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +60.35% |
| 50-Day Moving Average | 5.06 |
| 200-Day Moving Average | 4.60 |
| Relative Strength Index (RSI) | 49.70 |
| Average Volume (20 Days) | 1,381 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Massmedica had revenue of PLN 31.77 million and earned 618,273 in profits. Earnings per share was 0.26.
| Revenue | 31.77M |
| Gross Profit | 13.35M |
| Operating Income | 1.73M |
| Pretax Income | 990,085 |
| Net Income | 618,273 |
| EBITDA | 2.23M |
| EBIT | 1.73M |
| Earnings Per Share (EPS) | 0.26 |
Balance Sheet
The company has 408,212 in cash and 9.10 million in debt, with a net cash position of -8.69 million or -3.60 per share.
| Cash & Cash Equivalents | 408,212 |
| Total Debt | 9.10M |
| Net Cash | -8.69M |
| Net Cash Per Share | -3.60 |
| Equity (Book Value) | 6.11M |
| Book Value Per Share | 2.53 |
| Working Capital | 4.69M |
Cash Flow
In the last 12 months, operating cash flow was -1.13 million and capital expenditures -1.15 million, giving a free cash flow of -2.28 million.
| Operating Cash Flow | -1.13M |
| Capital Expenditures | -1.15M |
| Depreciation & Amortization | 497,097 |
| Net Borrowing | 2.75M |
| Free Cash Flow | -2.28M |
| FCF Per Share | -0.94 |
Margins
Gross margin is 42.03%, with operating and profit margins of 5.46% and 1.95%.
| Gross Margin | 42.03% |
| Operating Margin | 5.46% |
| Pretax Margin | 3.12% |
| Profit Margin | 1.95% |
| EBITDA Margin | 7.02% |
| EBIT Margin | 5.46% |
| FCF Margin | n/a |
Dividends & Yields
Massmedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.85% |
| FCF Yield | -17.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Massmedica has an Altman Z-Score of 2.01 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 4 |